Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.genrep.2021.101077 http://scihub22266oqcxt.onion/10.1016/j.genrep.2021.101077 33723522!7946539!33723522     free     free     free       Gene+Rep 2021 ; 23 (ä): 101077 Nephropedia Template TP {{tp|p=33723522|t=2021. ACE2: At the crossroad of COVID-19 and lung cancer |pdf=|usr=}}{{33723522}} gab.com Text ACE2: At the crossroad of COVID-19 and lung cancer JO: Gene Rep http://www.kidney.de/pget.php?&tw=1&pmid=33723522 #FOAvip Upregulation of Angiotensin Converting Enzyme-2 (ACE2) was frequently observed in patients with lung cancer. Interestingly, our recent study revealed that the same ACE2 receptor was also strongly upregulated in lungs during SARS-CoV2 infection. Therefore, it is possible that the upregulated expression of ACE2 in lung tumors might increase the susceptibility to COVID-19 infection in lung cancer patients. However, the molecular mechanism for the regulation of ACE2 is known neither in lung tumors nor in COVID-19. Under this review, we attempt to identify transcription factors (TFs) in the promoter of ACE2 that promote the expression of ACE2 both in COVID-19 infection and lung cancer. This review would decipher the molecular role of ACE2 in the upscaled fatality of lung cancer patients suffering from COVID-19. Twit Text FOAVip ACE2: At the crossroad of COVID-19 and lung cancer ????Gene Rep http://www.kidney.de/pget.php?&tw=1&pmid=33723522 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33723522 #FOAvip English Wikipedia <ref>{{Cite pmid|33723522}}</ref> ACE2: At the crossroad of COVID-19 and lung cancer #MMPMID33723522 Gottschalk G; Knox K; Roy A Gene Rep 2021[Jun]; 23 (ä): 101077 PMID33723522show ga Upregulation of Angiotensin Converting Enzyme-2 (ACE2) was frequently observed in patients with lung cancer. Interestingly, our recent study revealed that the same ACE2 receptor was also strongly upregulated in lungs during SARS-CoV2 infection. Therefore, it is possible that the upregulated expression of ACE2 in lung tumors might increase the susceptibility to COVID-19 infection in lung cancer patients. However, the molecular mechanism for the regulation of ACE2 is known neither in lung tumors nor in COVID-19. Under this review, we attempt to identify transcription factors (TFs) in the promoter of ACE2 that promote the expression of ACE2 both in COVID-19 infection and lung cancer. This review would decipher the molecular role of ACE2 in the upscaled fatality of lung cancer patients suffering from COVID-19. äACE2: At the crossroad of COVID-19 and lung cancer (epmc).pdf DeepDyve Pubget Overpricing